TEMPOL and TEMPOL-H for Fibrocystic Disease of Breast

Peter H Proctor-- Notice of Allowance

Claims

1. A method of treating fibrocystic disease of breast comprising administering to a patient in need thereof a therapeutically-effective amount of a compound selected from the Group consisting of TEMPO (2,2,6,6 tetramethyl-1-piperndinyl-1-oxyl), 4-hyroxy-Tempol, 4-aminoTEMPOL,TEMPO-H, and TEMPOL-H.

2. The method of claim 1 wherein the therapeutically-effective amount of a compound selected from the group consisting of TEMPO (2,2,6,6 tetramethyl-1-piperndinyl-1-oxyl), 4-hyroxy-Tempol, 4-amino-TEMPOL, TEMPO-H, and TEMPOL-H is .01-1000 mg. per day administered orally, sublingually, transrectally, intermuscularly, intravenously, or subcutaneously.

3. The method of claim 1 wherein the therapeutically-effective amount of a compound selected from the group consisting of TEMPO (2,2,6,6 tetramethyl-1-piperndinyl-1-oxyl), 4-hyroxy-Tempol, 4-aminoTEMPOL,TEMPO-H, and TEMPOL-H is administered along with a reducing agent.